Sale!

SCA-2 Spinocerebellar Ataxia ATXN2 Gene Mutation Test Cost

Original price was: 650 د.إ.Current price is: 590 د.إ.

-9%

The SCA-2 Spinocerebellar Ataxia ATXN2 Gene Mutation Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ATXN2 gene, which are responsible for Spinocerebellar Ataxia Type 2 (SCA-2). SCA-2 is a progressive, neurodegenerative disorder characterized by poor coordination of hands, speech, and eye movements, alongside other symptoms that worsen over time. Early detection through this genetic test can be crucial for managing the condition, enabling timely intervention and counseling for affected individuals and their families. The test is priced at 590 AED, making it accessible for those who suspect they may carry this mutation or have a family history of SCA-2, facilitating early and informed healthcare decisions.

Description

SCA-2 SPINOCEREBELLAR ATAXIA ATXN2 GENE MUTATION Test

Test Name: SCA-2 SPINOCEREBELLAR ATAXIA ATXN2 GENE MUTATION Test

Components: ATXN2 Gene

Price: 590.0 AED

Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery: SampleTue by 11 am; Report Sat

Method: PCR, Fragment analysis

Test type: Neurologic Disorder-Ataxia

Doctor: Neurologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Details:

The SCA-2 (Spinocerebellar Ataxia Type 2) test is a genetic test that detects mutations in the ATXN2 gene. Spinocerebellar ataxia is a group of genetic disorders characterized by progressive degeneration of the cerebellum and other parts of the nervous system, leading to problems with coordination, balance, and movement. The ATXN2 gene provides instructions for making a protein called ataxin-2. Mutations in this gene can result in the production of an abnormal ataxin-2 protein, which can accumulate in cells and interfere with their normal function.

The SCA-2 test involves analyzing a person’s DNA sample, usually obtained through a blood sample or cheek swab, to identify any mutations in the ATXN2 gene. This test can help confirm a diagnosis of SCA-2 in individuals with symptoms suggestive of the disorder, as well as identify carriers of the mutated gene who may be at risk of passing it on to their children.

It’s important to note that SCA-2 is an inherited disorder, typically passed down in an autosomal dominant pattern. This means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition.

The SCA-2 test can provide valuable information for individuals and families affected by SCA-2, allowing for early diagnosis, genetic counseling, and appropriate management and support. However, it is always recommended to consult with a healthcare professional or genetic counselor to fully understand the implications of the test results and discuss any concerns or questions.

Test Name	SCA-2 SPINOCEREBELLAR ATAXIA ATXN2 GENE MUTATION Test
Components	*ATXN2 Gene
Price	590.0 AED
Sample Condition	4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery	SampleTue by 11 am; Report Sat
Method	PCR, Fragment analysis
Test type	Neurologic Disorder-Ataxia
Doctor	Neurologist
Test Department:	MOLECULAR DIAGNOSTICS
Pre Test Information	Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details	The SCA-2 (Spinocerebellar Ataxia Type 2) test is a genetic test that detects mutations in the ATXN2 gene. Spinocerebellar ataxia is a group of genetic disorders characterized by progressive degeneration of the cerebellum and other parts of the nervous system, leading to problems with coordination, balance, and movement. The ATXN2 gene provides instructions for making a protein called ataxin-2. Mutations in this gene can result in the production of an abnormal ataxin-2 protein, which can accumulate in cells and interfere with their normal function. The SCA-2 test involves analyzing a person’s DNA sample, usually obtained through a blood sample or cheek swab, to identify any mutations in the ATXN2 gene. This test can help confirm a diagnosis of SCA-2 in individuals with symptoms suggestive of the disorder, as well as identify carriers of the mutated gene who may be at risk of passing it on to their children. It’s important to note that SCA-2 is an inherited disorder, typically passed down in an autosomal dominant pattern. This means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. The SCA-2 test can provide valuable information for individuals and families affected by SCA-2, allowing for early diagnosis, genetic counseling, and appropriate management and support. However, it is always recommended to consult with a healthcare professional or genetic counselor to fully understand the implications of the test results and discuss any concerns or questions.